Today: 28 June 2026
Browse Category

NASDAQ:ALT 25 November 2025 - 31 January 2026

Altimmune (ALT) Stock News Today (Dec. 17, 2025): Pemvidutide Catalysts, CEO Transition, and Wall Street Price Targets

Altimmune (ALT) Stock News Today (Dec. 17, 2025): Pemvidutide Catalysts, CEO Transition, and Wall Street Price Targets

Altimmune shares traded near $5.03 early Wednesday after closing at the same level Tuesday, with volatility elevated ahead of a key clinical update expected by year-end. The company’s valuation hinges on pemvidutide’s 48-week IMPACT Phase 2b readout for MASH, due in Q4 2025. Leadership changes and wide analyst price targets have added to market uncertainty. The stock jumped 12% intraday on Dec. 12 before retreating.
17 December 2025
·
Altimmune (ALT) Stock News, Forecasts and Analysis for Dec. 12, 2025: What Investors Are Watching Ahead of Pemvidutide Catalysts

Altimmune (ALT) Stock News, Forecasts and Analysis for Dec. 12, 2025: What Investors Are Watching Ahead of Pemvidutide Catalysts

Altimmune shares traded around $5.29 at 16:50 UTC on Dec. 12, 2025, down 0.9% after a volatile session with heavy volume. The company is preparing for a CEO transition on Jan. 1, 2026, as investors await key pemvidutide Phase 2b data and an FDA meeting. Analyst targets and options activity are adding to the stock’s swings.
12 December 2025
··
Altimmune (ALT) Stock: CEO Shake-Up, Imminent MASH Data and 250% Upside Forecasts as of December 9, 2025

Altimmune (ALT) Stock: CEO Shake-Up, Imminent MASH Data and 250% Upside Forecasts as of December 9, 2025

Altimmune closed at $5.61 on December 8, 2025, up 7% with heavy trading and high volatility, as short interest reached 30% of float. The company announced CEO Vipin Garg will step down January 1, 2026, with Chairman Jerry Durso taking over ahead of a key MASH trial readout. Analyst targets remain well above current prices despite recent revenue and EPS estimate cuts.
9 December 2025
·
ALT Stock Today (November 25, 2025): Altimmune Extends Rally as Pemvidutide Nears Critical FDA Moment

ALT Stock Today (November 25, 2025): Altimmune Extends Rally as Pemvidutide Nears Critical FDA Moment

Altimmune shares traded near $5.10 on November 25, up about 20% over two weeks after Phase 2b data for lead drug pemvidutide was published in The Lancet and highlighted at AASLD. The stock remains down over 50% from its December 2024 high, with investor sentiment tempered by ongoing shareholder lawsuits and a new $400 million shelf registration.
25 November 2025
··

Stock Market Today

  • Foreign Funds Dominate Ownership of Spain's Ibex 35 Stock Market
    June 28, 2026, 6:45 AM EDT. The Spanish stock market is increasingly controlled by foreign investors, with nearly 49% of shares owned by nonresidents as of 2024, rising to over 60% by market capitalization. Key players include investment giants BlackRock, Vanguard, and Norway's sovereign wealth fund. The trend reflects a reduction in household ownership from 35% in 1998 to under 16% today, aligning Spain with other EU markets like the UK and France. Experts note that international ownership brings enhanced corporate governance and market liquidity, though it also presents new challenges. The Ibex 35's revenue is also globally diversified, with 65% generated abroad. This shift highlights the global nature of Spain's equities and the growing role of international capital in its market.

Latest articles

Wall Street Feels the Heat (and Thrill): Fed Cuts, Tariffs & Mega-Mergers Set NYSE Buzz

US Stock Market Today: Live Updates 28.06.2026

28 June 2026
LIVEMarkets rolling coverageStarted: June 28, 2026, 4:00 AM EDTUpdated: June 28, 2026, 6:53 AM EDT Foreign Funds Dominate Ownership of Spain's Ibex 35 Stock Market June 28, 2026, 6:45 AM EDT. The Spanish stock market is increasingly controlled by foreign investors, with nearly 49% of shares owned by nonresidents as of 2024, rising to over 60% by market capitalization. Key players include investment giants BlackRock, Vanguard, and Norway’s sovereign wealth fund. The trend reflects a reduction in household ownership from 35% in 1998 to under 16% today, aligning Spain with other EU markets like the UK and France. Experts note
Go toTop